Background: Different yeast species have different susceptibilities to commonly prescribed antifungal drugs. Thus, it is important to accurately determine the species of pathogenic yeasts, especially when more than one species are in a specimen. Methods: Clinically significant yeast isolates were collected via the Taiwan Surveillance of Antimicrobial Resistance of Yeasts from July to September in 2010. The identifications of isolates were assessed in the core laboratory at the National Health Research Institutes. Results: Of the 1127 isolates recovered, 1088 were of Candida genus, accounting for 96.53% of the total isolates, followed by Cryptococcus (15, 1.33%), Trichosporon (12, 1.06%), Kodamaea (4, 0.35%), Pichia (4, 0.35%), and three others. In all, 38 out of 1116 (3.4%) specimens had mixed yeast cultures. One ascites specimen had three species, Candida albicans, Candida glabrata, and Candida tropicalis. In the remaining 37 specimens, 16 had a combination of C. albicans and C. glabrata, eight C. albicans and C. tropicalis, five C. glabrata and C. tropicalis, three Candida krusei and C. tropicalis, and five with different combinations. Conclusion: The high prevalence of cultures with mixed yeasts may be an emerging issue. Thus, to determine mixed yeast cultures in the same specimen, we highly recommend CHROMagar Candida medium to culture yeast isolates directly from the specimen.
Introduction
Due to the increased size of the populations at risk, the prevalence of yeast nosocomial infections has increased in the past decades. In the United States, yeast infections rank as the fourth most common cause of nosocomial bloodstream infection.
1,2 In Taiwan, the prevalence of nosocomial candidemia increased 27-fold from 1981 through 1993. 3, 4 Candida species are the most frequently isolated fungal pathogens causing morbidity and mortality in seriously immunocompromised hosts. Although Candida albicans is still the most prominent cause of candidemia, the prevalence of non-C. albicans yeast species has increased. 5e8 Candida krusei, Candida glabrata, and Candida tropicalis are less susceptible to fluconazole than other Candida species.
8e14 Candida lusitaniae is relatively resistant to amphotericin B.
15 Accurate identification to the species level is therefore crucial for clinical management, since different species have various degrees of susceptibility to common antifungal drugs.
Recently, we reported that among healthy volunteers, 5% had yeast colonization in oral cavities and 6.1% of those incidences were by multiple species. 16 Furthermore, we have also found that there has been an increase in the number of HIV-infected outpatients colonized by more than one species (from 7.9% before 2002 to 19 
Materials and methods

Organisms and media
From the 23 hospitals participating in TSARY, yeast isolates were collected according to procedures reported in previous studies 14, 20 from July 1 to September 30, 2010. Each hospital was asked to submit all yeast pathogens from sterile sites and the first 10 C. albicans and 40 non-C. albicans yeast isolates from non-sterile sites to the core laboratory at National Health Research Institutes (NHRI). Due to the collection criteria, the percentage of C. albicans from different sources was not calculated. In principle, only one isolate was accepted from each specimen. Nevertheless, when there were multiple species isolated from one specimen, one isolate from each species was analyzed. All the collected isolates were stored at À70 C in vials containing 50% glycerol.
Identification
Primary identification of the isolates was performed by the contributing TSARY hospitals. Then, the results were reassessed in the laboratory at the NHRI. All isolates identified as C. albicans by the TSARY hospitals were subjected to germ tube assay in media containing 10% fetal bovine serum (GibcoBRL, US-628531, Gel Company, CA, USA) at 37 C for 3e4 hours. The germ tube-positive isolates that failed to grow at 42 C were further analyzed by sequencing ribosomal DNA (rDNA). 21 All isolates identified as non-C. albicans yeasts by the TSARY hospitals were subjected to VITEK 2 (bioMérieux, Marcy l'Etoile, France). Cells in the vials were streaked onto CHROMagar Candida medium (CHROMagar, Paris, France) and the sequences of the rDNA were used for identification when one of the followings occurred: the identification probability of the VITEK 2 (bioMérieux, Marcy l'Etoile, France) was less than 85%; the identification of an organism was inconsistent between the hospital and the NHRI laboratories; uncommon species were reported; and potential mixed yeast cultures were observed during the germ tube assay. The internal transcribed spacer (ITS) region was amplified by the primers ITS1, 5
0 -TCCGTAGGT-GAACCTGCGG-3 0 , and ITS4 5 0 -TCCTCCGCTTATTGATATGC-3 0 and/or the D1/D2 region of rDNA was amplified by the primers NL1 5 0 -GCATATCAATAAGCGGAGGAAAAG-3 0 and NL4 5 0 -GGTCCGTGTTTCAAGACGG-3 0 .
21
Database and analysis
The database for this study contained the characteristic information of each submitted isolate: hospital origin, location and type of the hospital, identification and source of the isolate. The procedure for yeast identification used by each hospital was also collected. The statistical significance of the differences in frequencies and proportions was determined using the chi-square test with MantelHaenszel correction.
Results
Distribution of body sites
The mean number of isolates collected from the hospitals participating in the TSARY was 49 (ranging from 8 to 100) per hospital. The distribution of the 1127 isolates in different body sites is shown in Table 1 . Among 34 different body sites, urine (44.3%) was the most common source of yeast clinical isolates, followed by blood (19.8%), sputum (13.1%), catheter tip (4.8%), wound (3.7%), ascites (2.9%), pus (2.7%), bronchial washing (2%), and 23 other different body sites (6.7%).
Distribution of species
Candida was the most common genus found, accounting for 96.53% (1088/1127) of the total isolates, followed by Cryptococcus (15, 1.33%), Trichosporon (12, 1.06%), Kodamaea (4, 0.35%), Pichia (4, 0.35%), and one each of Rhodosporidium, Rhodotorula, and Sterigmatomyces. Among the 223 isolates recovered from blood, C. albicans (103, 46.2%) was the most common species, followed by C. tropicalis (41, 18.4%), C. parapsilosis (35, 15.7%), C. glabrata (22, 9.8%), Cryptococcus neoformans (8, 3.6%), C. krusei (2, 0.9%) and 10 other species (12, 5.4%), see Table 1 . Although the prevalence of C. albicans was underestimated due to the collection criteria, it was still the most common species among the 1127 isolates collected in the present study (423 isolates, 37.6%). C. tropicalis (270, 24%) and C. glabrata (262, 23.2%) were the two major non-C. albicans yeast species, followed by C. parapsilosis (87, 7.7%), C. krusei
Since we asked the hospitals to collect the first 10 C. albicans and 40 non-C. albicans yeast isolates from nonsterile sites, there is a possibility that the specimens in the vials just represented part of those cultured in the hospital laboratories. Thus, the rate (38/1116, 3.4%) of mixed yeast cultures in the present study is most likely underestimated. Among the 38 specimens containing mixed yeast cultures, 16 were from urine, 13 from sputum, two from ascites, two from blood, one each from bronchial washing, catheter tip, nail, skin, and pus (Table 2 ). C. albicans appeared to be the most common species co-recovered with others, accounting for 73.7% of the cases, followed by C. glabrata (57.9%) and C. tropicalis (44.7%). These three species were corecovered from one ascites specimen. Furthermore, 16 out of the remaining 37 specimens had a combination of C. albicans and C. glabrata. In general, on CHROMagar Candida medium, C. albicans colonies were green, C. glabrata were pink to dark purple, C. krusei fuzzy rose with white edges, C. parapsilosis white, and C. tropicalis steel blue accompanied by purple pigment diffusion into the surrounding agar (Fig. 1A) . When the cells from the 18 vials containing mixed yeast culture were streaked onto CHROMagar Candida medium in the NHRI laboratory, 16 had colonies in two different colors. The combination of C. albicans and C. glabrata (Fig. 1A  aej) , C. krusei and C. tropicalis (Fig. 1A oep) , C. glabrata and C. tropicalis (Fig. 1A q) , as well as C. albicans and C. parapsilosis (Fig. 1A r) , could be distinguished when the cells were streaked onto CHROMagar Candida medium. However, under this condition, C. albicans from two vials containing the combination of C. albicans and C. tropicalis Table 1 The distribution of body sites and yeast species Source failed to show up (Fig. 1A k and l) . When streaking more cells (one vial per agar plate) from the oYM100104 and oYM100109 vials onto CHROMagar Candida medium, we were able to find several green colonies (arrows) of C. albicans from the oYM100104 vial ( Fig. 2A) but not from the oYM100109 (Fig. 2B) . When the mixed yeast cells were patched onto CHROMagar Candida medium (Fig. 1B) , only the color of the dominant species would show up.
Methods of identification
Discussion
The distribution of species in the present study was similar to those in previous TSARYs. 12, 14, 20 With the exception of blood, the distributions of species found at various body sites in the present study were not significantly different from those in previous TSARY surveys. 14, 20, 22 The reason that the proportion of isolates from blood in the present study (223/1127) was higher than those in the 2002 (130/ 945 p Z 0.0003) and 2006 TSARY (160/1015 p Z 0.02) needs further investigation.
Among the 38 specimens containing mixed yeast cultures, 17 had a combination of C. albicans and C. glabrata. Since the clinical treatments for infections caused by these two species may be different, 8, 11, 23 it is important to accurately differentiate these two species, especially when they are present in the same specimen.
There are some limitations of CHROMagar Candida medium. For example, when the ratio of two species was significantly different, the medium failed to detect the minority (Figs. 1A k and l, and 2B ). The medium is not capable of detecting mixed yeast cultures in the same specimen if the cells were patched onto it (Fig. 1B) . The fact that in the present study, the hospital using only CHROMagar Candida medium for yeast identification misidentified C. parapsilosis as C. glabrata demonstrates that CHROMagar Candida medium provides presumptive but not definite identification of yeast species. Despite the limitations, CHROMagar Candida is still a helpful tool in facilitating the recognition of mixed yeast cultures. 24 Application of CHROMagar Candida medium to culture yeast isolates directly from the specimen is therefore highly recommended, particularly the specimens from patients who did not respond well to the treatment or the specimens from the sterile sites. The most critical point is that hospital technologists should be aware of the increasing possibility that one patient may be infected by more than one fungal species.
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